Brett R. Havranek

FDA investigator

Appears on 6 documents from 2015 to 2018, mostly at sites in Kansas. Most often cites production record review (21 CFR 211.192).

6
Documents on file
6.7
Observations per 483
2015
First seen
2018
Most recent

What they cite most

From 40 observations

Activity by year

2015: 1, 2016: 2, 2017: 1, 2018: 2

Where

Kansas 4 · Canada 2

Is Brett R. Havranek coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Jubilant HollisterStier General PartnershipJun 1, 2018 · Kirkland, Canada
483 Groupe PARIMA Inc.Apr 27, 2018 · Montreal, Canada
483 Cramer Products IncApr 14, 2017 · Gardner, Kansas
483 Fagron Compounding Services LLC dba Fagron Sterile ServicesSep 21, 2016 · Wichita, Kansas
483 Hospira Inc. A Pfizer CompanyJun 8, 2016 · McPherson, Kansas
483 JCB Laboratories LLCDec 3, 2015 · Wichita, Kansas

About this profile

What does Brett R. Havranek inspect?

Brett R. Havranek appears on 6 documents on file covering 6 sites, mostly in Kansas.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.68 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Brett R. Havranek is dated Jun 1, 2018.